Is BWIN a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for The Baldwin Insurance Group (BWIN) rests on Organic growth across operating groups: Baldwin has historically posted double-digit organic revenue growth, though the pace slowed to about 2 percent in the first quarter of 2026. Revenue (2025) is ~$1.5B. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: Baldwin runs at a GAAP net loss while reporting positive adjusted earnings, so the gap between the two, driven by amortization, interest, and deal costs, is a meaningful risk if adjusted metrics do not eventually convert to reported profit. Whether BWIN is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
The Baldwin Insurance Group, Inc. (formerly BRP Group) is an independent insurance brokerage and advisory firm headquartered in Tampa, Florida, and founded in 2011. It distributes personal and commercial insurance through three operating groups: Insurance Advisory Solutions (middle-market and larger commercial clients), Mainstreet Insurance Solutions (personal lines and Medicare), and Underwriting Capacity and Technology Solutions, which houses managing general agent (MGA) programs that let Baldwin design its own specialty products and capture more of each transaction's economics. Its advisors assess client risk and place coverage across a broad carrier network, blending traditional brokerage with technology-enabled product development. The investment picture centers on rapid top-line growth from both organic expansion and acquisitions, set against thin GAAP profitability. Full-year 2025 revenue grew about 8 percent to roughly $1.5 billion, while the company posted a net loss, and adjusted EBITDA margin ran around 23 percent. In early 2026 the CAC Group merger drove a 29 percent revenue jump in the first quarter, though organic growth cooled to about 2 percent. Management's 3B30 plan targets $3 billion of revenue and a 30 percent EBITDA margin by 2029, so the stock is largely a bet on Baldwin sustaining growth and lifting margins while integrating deals and carrying meaningful debt.
What's the case for buying BWIN?
1. Organic growth across operating groups
Baldwin has historically posted double-digit organic revenue growth, though the pace slowed to about 2 percent in the first quarter of 2026. Sustained mid-to-high single-digit or better organic growth across its middle-market, personal lines, Medicare, and specialty MGA businesses is the core driver, since organic expansion carries higher-quality economics than acquired revenue.
2. Acquisitions and partnership integration
The company has grown substantially through mergers, most recently completing its combination with CAC Group in January 2026, which added specialty and middle-market capabilities and powered a 29 percent jump in first-quarter 2026 revenue to about $532 million. Successfully integrating acquired firms and cross-selling across the platform is central to Baldwin's scale story.
3. Margin expansion and the 3B30 plan
Management's 3B30 target aims for roughly $3 billion of revenue and a 30 percent adjusted EBITDA margin by 2029, up from about a 23 to 26 percent margin recently. The plan leans on AI, automation, and operating leverage. Progress toward these goals, and closing the gap between adjusted and GAAP earnings, is a key part of the thesis.
4. Specialty MGA and underwriting economics
Through its Underwriting Capacity and Technology Solutions group, Baldwin builds its own insurance products via MGA platforms, capturing more economics per transaction than pure brokerage. Growth in proprietary specialty programs can lift margins and differentiate Baldwin, though it also ties results more closely to underwriting and carrier-capacity conditions.
What are the risks to BWIN?
Baldwin runs at a GAAP net loss while reporting positive adjusted earnings, so the gap between the two, driven by amortization, interest, and deal costs, is a meaningful risk if adjusted metrics do not eventually convert to reported profit. The company carries substantial debt from its acquisition strategy, making it sensitive to interest rates and integration missteps. Organic growth has decelerated recently, and a slowdown would pressure the valuation. Results also depend on insurance pricing cycles, carrier capacity, and competition from much larger, better-capitalized brokers. Free cash flow has at times been near breakeven, which limits financial flexibility.
How is BWIN valued? (as of July 2026)
Snapshot for BWIN as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (2025): ~$1.5B
- Q1 2026 revenue: ~$532M
- Q1 2026 organic growth: ~2%
- Adjusted EBITDA margin (Q1 2026): ~26%
- Market cap: ~$4B
- GAAP EPS: net loss
As of July 2026, BWIN trades around a $4 billion market cap with shares near the high-$20s, and its trailing GAAP P/E is negative because the company reports a net loss. Investors instead value it on adjusted earnings (adjusted diluted EPS was about $0.63 in the first quarter of 2026) and on revenue and EBITDA growth, so the multiple reflects a growth-and-margin story rather than current GAAP profitability.
How do you decide if BWIN is a buy?
Rather than asking whether BWIN is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold BWIN indirectly through an index or sector ETF before adding more.
For the full picture, see the BWIN stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about BWIN against your real portfolio and see your actual exposure before deciding.
The bottom line on BWIN
The bottom line: The Baldwin Insurance Group's story right now is Organic growth across operating groups, with revenue (2025) at ~$1.5B. If you believe that narrative continues, the call is about sizing BWIN sensibly and checking overlap with what you own; if you doubt it (the risk: baldwin runs at a GAAP net loss while reporting positive adjusted earnings, so the gap between the two, driven by amortization, interest, and deal costs, is a meaningful risk if adjusted metrics do not eventually convert to reported profit.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around BWIN with Walnut
Use The Baldwin Insurance Group as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is BWIN a good stock to buy right now?
+
The case for The Baldwin Insurance Group right now is Organic growth across operating groups, with revenue (2025) at ~$1.5B. If you believe that thesis holds, BWIN is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is baldwin runs at a GAAP net loss while reporting positive adjusted earnings, so the gap between the two, driven by amortization, interest, and deal costs, is a meaningful risk if adjusted metrics do not eventually convert to reported profit. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does The Baldwin Insurance Group do?
+
The Baldwin Insurance Group, Inc.
What are the main risks of BWIN?
+
Baldwin runs at a GAAP net loss while reporting positive adjusted earnings, so the gap between the two, driven by amortization, interest, and deal costs, is a meaningful risk if adjusted metrics do not eventually convert to reported profit. The company carries substantial debt from its acquisition strategy, making it sensitive to interest rates and integration missteps. Organic growth has decelerated recently, and a slowdown would pressure the valuation. Results also depend on insurance pricing cycles, carrier capacity, and competition from much larger, better-capitalized brokers. Free cash flow has at times been near breakeven, which limits financial flexibility.
What does The Baldwin Insurance Group do?
+
Baldwin is an independent insurance brokerage and advisory firm. It places personal and commercial insurance for clients across a network of carriers, and through its MGA platform it also designs its own specialty insurance products to capture more of each transaction's economics.
Is BWIN the same company as BRP Group?
+
Yes. The company was formerly known as BRP Group, Inc. and changed its name to The Baldwin Insurance Group, Inc. in May 2024. It is now listed on the Nasdaq under the ticker BWIN.
How does Baldwin make money?
+
It earns commissions and fees for placing insurance coverage between clients and carriers across middle-market, personal lines, and Medicare segments. Its specialty MGA programs generate additional underwriting-related economics by building proprietary insurance products.
Why does BWIN show a negative P/E ratio?
+
Baldwin has been reporting a GAAP net loss, driven by items such as amortization of acquired intangibles, interest expense, and deal-related costs, which produces a negative trailing P/E. The company still reports positive adjusted earnings and adjusted EBITDA.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell BWIN; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.